Author
University of California, San FranciscoORCID 0000-0002-1489-1348Unclaimed ORCID profile · follow to get notified of new preprints
5 papers
Recent·Most cited
Gabrielle Perron, Mohan Amaravadi, Cynthia Tseng…·Hamed Shateri Najafabadi
The paper maps regulatory connections between RBPs and miRNAs in cancer, showing RBP-driven regulation contributes to miRNA activity heterogeneity and identifies DDX55 as a key regulator of miR-29-3p.
Johnny X. Yu, Jung Min Suh, Katerina D. Popova…·Hani Goodarzi
This study uses GENEVA to analyze drug response variations in cancer cells, revealing mitochondrial activation's role in KRAS inhibition and EMT as a resistance mechanism.
Benjamin D. Hobson, Adrien T. Stanley, Mark B. De Los Santos…·David L. Sulzer
The paper shows IFN-γ induces MHC-I expression in ventral midbrain neurons and glia, but with lower amplitude in neurons, and MHC-II is restricted to microglia.
Johnny X. Yu, Albertas Navickas, Hosseinali Asgharian…·Hani Goodarzi
The paper identifies RBMS1 as a suppressor of colon cancer metastasis by stabilizing its mRNA targets, showing its clinical relevance in patient survival.
Lisa Fish, Albertas Navickas, Bruce Culbertson…·Hani Goodarzi
The paper identifies TARBP2 as a nuclear RNA-binding protein that regulates transcript stability through m6A methylation, splicing inhibition, and exosome-mediated degradation, with implications for lung cancer progression.